Devic's disease with serological confirmation;Doença de Devic com Confirmação Serológica

Sinapse

Volumn 6, Issue 1, 2006, Pages 69-74

  Guimarães, Joana ^a   Wingerchuk, Dean ^b   Sá, Maria José ^a,c  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b MAYO CLINIC   (United States)

^c University of Porto   (Portugal)

Author keywords

Antibody NMO IgG; Multiple sclerosis; Neuromyelitis optica

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; GLATIRAMER; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; OLIGOCLONAL BAND;

ADULT; ANAMNESIS; ANTIBODY DETECTION; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CONVALESCENCE; DEMYELINATING DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DRUG PULSE THERAPY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPESTHESIA; MOTOR PERFORMANCE; MYELOOPTIC NEUROPATHY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; OUTPATIENT DEPARTMENT; PARAPLEGIA; PARESIS; PROGNOSIS; SEROLOGY; TREATMENT OUTCOME; TREATMENT PLANNING; URINE RETENTION; WHEELCHAIR; WHITE MATTER;

EID: 33745314785     PISSN: 1645281X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Mandler RN, Davis LE, Jeffery DR, Kornfeld M. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 1993; 34: 162-68.
2. O'Riordan JI, Gallagher HL, Thompson AJ, et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 1996; 60: 382-87.
3. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica. (Devic's syndrome). Neurology 1999; 53: 1107-14.
4. Cree BA, Goodin DS, Hauser SL. Neuromyelitis optica. Semin Neurol 2002; 22: 105-22.
5. Albutt TC. On the ophtalmoscopic signs of spinal disease. Lancet 1870; 1: 76-8.
6. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serumk autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-12.
7. Wingerchuk DM, Weinshenker BG. Neuromyelitis Optica. Curr Treat Options Neurol. 2005; 7: 173-82.
8. Weinshenker BG. Neuromyelitis optica: what it is and what it might be. Lancet 2003; 361: 889-90.
9. de Seze J, Lebrum C, Stojkovic T, Ferriby D, Chatel M, Vermersch P. Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis. Mult Scler 2003; 9: 521-25.
10. Ghezzi A, Bergamachi R, Martinelli V, et al. Clinical characteristics, course and prognosis of relapsing Devic's neromyelitis optica. Brain 2002; 125: 1450-6.1
11. Mandler RN, Ahmed W, Dencoff JE. Devic's Disease, neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 1998; 51: 1219-20.
12. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 2002; 58: 143-46.
13. Lucchinetti CF, Mander RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125: 1450-61.
14. Gold R, Linington C. Devic's disease: bridging the gap between laboratory and clinic. Brain 2002; 125: 1425-27.
15. Hummers LK, Krishnam C, Casciola-Rosen L, et al. Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology 2004; 62: 147-49.
16. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Shannon RH. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005; 202: 473-77.
17. Scolding N. The differential diagnosis of Multiple Sclerosis. J Neurol Neurosurg Psychiatry 2001; 71: 9-10.
18. McDonald WI, Compson A, Edan G, et al. Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the diagnosis of Multiple sclerosis. Annals of Neurology 2001; 50: 121-27.
19. Weinshenker B. Western vs optic-spinal MS: two diseases, one treatment?. Neurology. 2005; 64: 594-5.
20. Barkhof F, Fillippi M, Miller DH. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059-69.
21. Tintoré M, Rovira A, Martinez MJ Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis AJNR Am J Neuroradiol. 2000; 21: 702-6.
22. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in Neuromyelitis Optica. Arch Neurol. 2006; 63: 390-91.
23. Weinshenker BG, Wingerchuk DM, Vukusic S, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006; 59: 566-69.